Bevacizumab-Based Therapy for Patients with Brain Metastases from Non-Small-Cell Lung Cancer: Preliminary Results
Conclusions: Bevacizumab-based therapy proved to be feasible and safe. The PFS and the OS data are very encouraging as well as the symptomatic benefit due to bevacizumab's high capacity to provide a long-lasting decrease of perilesional edema.Chemotherapy 2014;60:294-299
Source: Chemotherapy - Category: Cancer & Oncology Source Type: research
More News: Avastin | Bleeding | Brain | Brain Cancers | Cancer | Cancer & Oncology | Chemotherapy | Employment | Lung Cancer | Neurology | Non-Small Cell Lung Cancer